6 Weird (But Totally Normal) Things About Your Newborn - Middle East Business News and Information
Welcoming a newborn is an exciting experience, but it can come with some surprises. Babies are tiny, adorable, and sometimes puzzling. If you've noticed some unusual behaviors in your little one, rest assured—many of these quirks are completely normal. Here are six common but strange things you might notice with your newborn.
Newborns' eye muscles are still developing, so it's common for their eyes to wander or cross, especially when they're tired. This might look concerning, but it's usually just their way of learning to coordinate vision. By about 4 months[1] their eyes should align consistently. In the meantime, stimulate their sight with a high-contrast mobile above their crib (securely fastened, of course!). Soft, natural lighting in the nursery can also help them adjust without overstimulation.
Your baby's velvety skin might start flaking or peeling in their first weeks. This is a natural process as they shed the protective vernix they were born with. A lukewarm bath and very gentle cleansing are all that's needed—sometimes, just a light dab of a trusted baby lotion, can help maintain that natural moisture balance. The key is to use these products sparingly, keeping the focus on gentle care without overdoing it. [2]
Those tiny red bumps on their cheeks? Baby acne, or neonatal acne, is a common skin condition that typically emerges between two to four weeks after birth. Characterized by tiny red or white pimples on a baby's cheeks, nose, or forehead, it affects about 20% of newborns. The exact cause isn't fully understood, but it's believed to be related to hormonal changes that stimulate the baby's oil glands. Fortunately, baby acne usually resolves on its own within a few weeks to months without leaving scars. To care for your baby's delicate skin, gently cleanse their face with lukewarm water and a soft cloth, with baby-safe soap or cleanser (and avoid scrubbing!). If the acne persists beyond a few months or appears severe, consult your pediatrician for further guidance. [3] [4]
Hiccups are a reflex caused by their immature diaphragm adjusting to breathing, swallowing, or even feeding. While the 'hic!' sounds dramatic, they rarely bother babies. To ease them, try holding your little one upright after feeds in a quiet corner of the nursery. If hiccups strike during playtime, lean into the moment. They're a sign their nervous system is developing just right! [5]
That adorable jerk of the arms when they hear a loud noise? It's the Moro reflex, an instinctual response to stimuli. While startling, this reflex usually fades by about 5 to 6 months. Swaddling can help them feel secure (make sure their hips have room to move!). Pair this with a safe sleep environment: a firm crib mattress, no loose blankets, and a room free of dangling cords or bright lights. [6] Sleep Challenges and Quirky Patterns:
Newborn sleep can be as unpredictable as it is endearing. It's common for infants to follow a polyphasic sleep pattern meaning they sleep in several short bursts throughout the day and night rather than in one long stretch. Some evenings, you might notice your baby seems wide awake or unusually restless. These variations are part of their natural developmental process as they gradually build a more regular sleep routine. [7] If you're finding it tricky to settle your little one, you might enjoy trying out the Johnson's 2-Step Baby Sleep Routine. It's a simple approach involving just a gentle cuddle and a quiet moment together that helps signal bedtime. Many parents find that this easy routine can gradually encourage a more consistent sleep pattern without any fuss.
Newborns are full of surprises, and while some of their quirks might seem strange, they're usually just part of their development. Remember, every baby is unique, and what's normal for one might not be for another. If you're ever unsure, don't hesitate to reach out to your pediatrician. After all, parenting is a journey of learning and embracing the weird and wonderful moments along the way.
This article is not intended as medical advice and is for informational purposes only.
About Kenvue:
Kenvue is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Nicorette®, Aveeno®, Listerine®, Neutrogena®, and Johnson's® Baby are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
21 hours ago
- Mid East Info
Dubai-Based IT Company Wins Prestigious HR-Award for Employee Engagement and Happiness - Middle East Business News and Information
Reputation House was named among this year's winners alongside Dubai Health Authority, Abu Dhabi Customs, and the Ministry of Education of the UAE Reputation House – a Dubai-based IT company – has been named the winner of the 2025 Stevie® Awards for Great Employers in the category of Engagement/Happiness Team of the Year. The category that recognizes outstanding initiatives designed to boost employee engagement and workplace well-being. The company joins a distinguished group of winners from the United Arab Emirates, including Dubai Health Authority, Abu Dhabi Customs, and the Ministry of Education, all honored for their exceptional efforts in building thriving workplace cultures. 'We're honored to stand alongside national offices like Dubai Health Authority and Abu Dhabi Customs. As a Dubai-born company expanding our global footprint, this award affirms our mission to bring human-centered digital solutions to teams around the world, ' said Dima Raketa, CEO at Reputation House. The jury praised Reputation House for its human-centered approach and impactful internal programs, including: A company-wide focus on people and unlocking individual potential; Internal educational and coaching sessions that empower any team member to become a speaker; Bilingual corporate newsletters and monthly digest; A culture of gratitude and peer recognition. 'This award is more than just recognition — it's proof that when you invest in people and build an environment of trust, the results speak for themselves. Our team is our greatest strength, and we're proud of what we've built together. Many of our team members work remotely across different countries, time zones, and cultural backgrounds — and we strive to create conditions that support everyone. We continuously invest in initiatives that enhance both engagement and employee happiness,' said Kristina Shinkareva, the company's Chief Operating Officer. 'We believe in our people and they believe in us. That mutual trust is what allows us to build a cohesive, motivated team in modern hybrid and remote realities. We actively invest in a positive workplace culture, and it's rewarding to see that investment recognized on a global scale. This award belongs to the entire Reputation House team — to the culture we're creating together,' said Daria Skladchikova, the company's HR Director. In 2024, Reputation House was named the most awarded reputation management firm in the UAE, and this year's recognition further cements its position as a national and global leader in people-first innovation. The Stevie® Awards for Great Employers is one of the most respected global accolades celebrating excellence in HR, workplace culture, and leadership. Winners are selected by an international panel of judges and represent the highest standards of innovation and impact in employee experience.
Mid East Info
10-07-2025
- Mid East Info
PharmaJet® Enters into MOU Agreement with Egyptian UPA and EVA Pharma to provide Needle-Free Delivery for Routine Immunization in Egypt
PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, today announced that it has signed a Memorandum of Understanding (MOU) agreement with the Egyptian Unified Procurement Authority (UPA) and EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East and Africa, to explore the integration of needle-free delivery of inactivated polio vaccine into Egypt's routine immunization program. The signing event took place in Cairo at the African Health ExCon healthcare conference on June 26. The agreement includes provisions for distribution, technology transfer, manufacturing, and new pharmaceutical product development, as well as collaborating to increase needle-free access within Egypt and regionally. The UPA seeks to incorporate new technologies into its portfolio, aiming to expand the benefits of vaccination against certain infectious agents, improve pandemic preparedness, reduce total immunization costs, and improve foreign exchange rates. Tropis® Needle-free adoption offers several strategic advantages for Egypt including substantial immunization cost savings of 38% or more over six years1, reduced vaccine hesitancy2,3, increased coverage2, and the potential for medical technology localization. EVA Pharma is a leading pharmaceuticals and medical appliances manufacturing company that has vast experience in manufacturing, registering, marketing, and promoting pharmaceutical products. 'This collaboration can transform immunization by making it safer, more accessible, and less painful for children and caregivers,' said Nicolas Boege, Director of Global Commercial & Corporate Development at EVA Pharma. 'By introducing this technology, alongside localized technology transfer and manufacturing, EVA Pharma is committed to scaling innovation that strengthens public health systems. We are proud to collaborate with UPA and PharmaJet to localize needle-free delivery and accelerate its integration into Egypt's immunization programs and beyond.' The adoption and introduction of Tropis with concurrent manufacturing technology transfer has the potential to advance UPA's goal of becoming the leader of immunization excellence and a hub of needle-free product manufacturing for the Middle East and Northern Africa. The current initiative will enhance pandemic preparedness, reduce immunization costs, and support Egypt's Universal Health Insurance project. It also emphasizes the critical importance of the first 1,000 days in a child's life, building on the earlier efforts of the '1000 Golden Days' presidential initiative. 'This collaboration with UPA and EVA Pharma has the potential to enable the children of Egypt to gain from the benefits of intradermal (ID) delivery with reduced pain and administration time. The UPA would benefit through cost savings and novel pharma product development and manufacturing opportunities with needle-free delivery, and we would be thrilled to expand PharmaJet's commercial applications into Egypt and regionally. It's a win-win all around,' said Paul LaBarre, Vice President of Business Development for PharmaJet. 'We look forward to contributing to early childhood development in this region by increasing the positive impact of needle-free immunization.' Tropis ID has been widely used for inactivated polio vaccine delivery in campaigns and supplemental immunization activities. It has been rigorously evaluated in a routine immunization setting in two recently published studies that showed greater than 94% acceptability amongst healthcare workers and caregivers3, reduced administration time3, and greater than 50% reduction in immunization adverse events compared with intradermal delivery with a needle.
Mid East Info
07-07-2025
- Mid East Info
Kenvue Releases Second Annual Healthy Lives Mission Report Highlighting Progress in Reducing Emissions and Advancing More Sustainable Product Innovation
Company reports reduction of operational emissions by 37%, expanded use of renewable electricity to 72% and launch of multiple packaging innovations across portfolio Kenvue Inc. NYSE: KVUE, maker of iconic brands such as Neutrogena®, Listerine®, Aveeno®, and Tylenol® , today released its second Healthy Lives Mission Report. The report shares how Kenvue has helped advance the well-being of both people and planet in 2024, with progress noted across three pillars: Healthy People, Healthy Planet, and Healthy Practice. 'Having some of the most recognizable consumer brands in the world gives us a tremendous opportunity to create a positive impact for the millions of people we touch every day,' said Thibaut Mongon, Chief Executive Officer, Kenvue. 'Whether improving our packaging to be more sustainable, advancing the decarbonization of our operations, or giving back to our communities, our sustainability strategy is helping meet customer and consumer expectations, and deliver everyday care for generations to come.' Since becoming an independent company in 2023, Kenvue has invested in research and development, hired experts in areas like packaging, embedded sustainability into key functions and designed a sustainability strategy purposefully built to meet critical commitments and deliver superior consumer experiences and products. Highlights from the report include: Healthy People: Nicorette® QuickMist became the first nicotine replacement therapy (NRT) in the U.K. to be licensed to help vapers quit, with this vaping cessation indication now included across the whole Nicorette® range in the U.K. Helped train health care professionals (HCPs) in Malaysia on the use of NRT solutions like Nicorette® and worked with the Health Minister of Malaysia to launch its Cik Era (Miss Era) AI chatbot on the JomQuit (Come On, Quit) website, which offers smokers personalized support and advice on quitting smoking. Trained more than 7,000 Walgreen's pharmacists and 12,000 beauty consultants since 2020 through a collaboration between Neutrogena® and the Melanoma Research Foundation (MRF) on the importance of recommending sunscreen to consumers. Addressed women's health by destigmatizing conversations about menstruation in India led by Stayfree®, and menopause in the U.S with the launch of Versalie™, a digital platform dedicated to menopause and women's hormonal wellness. Launched health initiative in India to help reduce diarrhoea-related mortality and improve healthcare outcomes with an aim to reach approximately 5 million children under the age of five over the next two years. Kenvue donated more than $56 million to support communities in need. Healthy Planet: Reduced Scope 1 and 2 emissions 1,2,3 by 37% from a 2020 base year, toward a 42% reduction goal by 2030 4 . by 37% from a 2020 base year, toward a 42% reduction goal by 2030 . Expanded the use of renewable electricity 5 to 72% across global operations, with Latin America maintaining 100% renewable electricity 5 since 2023. to 72% across global operations, with Latin America maintaining 100% renewable electricity since 2023. Transitioned 69% of packaging 6 across portfolios to be recyclable 7 or refillable 8 , with a goal of 100% by 2025 4 . across portfolios to be recyclable or refillable , with a goal of 100% by 2025 . Reduced the use of virgin plastic 9 in packaging 6 by more than 21.4% from a 2020 base year, with goals of 25% by 2025 4 and 50% by 2030 4 . in packaging by more than 21.4% from a 2020 base year, with goals of 25% by 2025 and 50% by 2030 . Several Kenvue brands have contributed to this progress with redesigned packaging: Zyrtec® switched from plastic blister packs to paper, saving more than 1,520,000 pounds of plastic annually. Johnson's® Baby in Latin America launched shampoo and bath products in refillable, recycle-ready pouches. Dabao® in China made their plastic bottles lighter, saving over 264,000 pounds of plastic. Healthy Practice: Integrated sustainability into research and development with the launch of the Sustainable Innovation Profiler, a patent-pending tool designed to measure a product's environmental performance and enable developers to make real-time choices to design solutions that benefit both people and the planet. This tool is now embedded in Kenvue's product development process across R&D. The tool, already operational, helped inform design solutions to improve the packaging performance for several products including: OGX® Argan Oil Shampoo and Conditioner bottles: Redesigned to address consumer feedback, including improved 'squeezability', a reduced product environmental impact and total carbon footprint, and improved green chemistry and packaging with a fully recyclable, 100% Post-Consumer Recycled High-Density Polyethylene (PCR HDPE) bottle. Nicorette® Icy Mint Lozenge: Revamped its primary packaging, reducing plastic waste by 85% and reducing the product's total carbon footprint by 17%, compared to the previous version. About Kenvue: Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Cautions Concerning Forward-Looking Statements: This media alert contains 'forward-looking statements' as defined in the Private Securities Litigation Reform Act of 1995, including forward-looking statements related to the Healthy Lives Mission and its related goals and commitments. Forward-looking statements may be identified by the use of words such as 'plans, 'expects,' 'may,' 'will,' 'anticipates,' 'estimates,' 'intends,' 'goal,' 'target,' 'commitment,' and other words of similar meaning. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue Inc. and its affiliates. A list and descriptions of risks, uncertainties, and other factors can be found in Kenvue Inc.'s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 29, 2024, and subsequent Quarterly Reports on Form 10-Q and other filings, available at or on request from Kenvue Inc. Kenvue Inc. and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise. Footnotes: 1 Applies to all Kenvue-owned facilities where Kenvue has operational control, regardless of building type; all leased facilities used for manufacturing and/or research and development; and leased, non-manufacturing and/or non-research and development facilities where the facility is greater than 50,000 square feet and where Kenvue has operational control. The 2020 base year and all subsequent reporting years include all facilities aligned to Kenvue's structure upon separation from Johnson & Johnson in 2023 and do not include any operational or organizational exclusions. 2 The target boundary includes land-related emissions and removals from bioenergy feedstocks. 3 The inventory was compiled in accordance with the World Resources Institute (WRI)/World Business Council for Sustainable Development (WBCSD) (GHG) Protocol – A Corporate Accounting and Reporting Standard (Revised Edition 2013) including the amendment to this protocol, GHG Protocol Scope 2 Guidance (2015). 4 We aim to meet the goal by end of fiscal year and publish the year after. 5 Renewable energy source is an energy source that is capable of being replenished in a short time through ecological cycles or agricultural processes (e.g., biomass, geothermal, hydro, solar, wind). Renewable electricity targets are achieved through a combination of actions, including on-site solar, virtual power purchase agreements (VPPAs), direct power purchase agreements (PPAs), energy attribute certificates (EACs), also known as renewable electricity certificates (RECs), and green retail contracts. 6 Packaging for direct purchases may not include all externally manufactured products. Total weight of plastics packaging is calculated utilizing 2025 Business Plan volume and is not trued up to actual sales. Manual adjustments of <10% were made to 2025 Business Plan volume based on SME judgment to remove materials not assumed to contain plastics. 7 Recyclable, also defined as recycle-ready, is when packaging is designed for collection, sorting, and recycling using end of-life processes, but where collection, sorting and recycling infrastructure may not yet be in place for the packaging to actually be recycled. Best practices of 'designing for recyclability' guidance for plastic-based packaging include the Association of Plastics Recyclers in the U.S. Note: 'Designed for recycling,' 'designed for recyclability,' and 'recycle ready' are also used interchangeably and reflect the same meaning. Recyclability % was assessed using Ellen MacArthur Foundation recycling rate guidelines and Consumer Goods Forum golden design rules guidelines. For pure buy, data assumptions were made on recyclability at brand level. 8 Kenvue defines refillable or reusable packaging as packaging that is designed for either the business or the consumer to put the same type of purchased product back into the original packaging, is designed to be returnable and/or refillable, and accomplishes a minimum number of reuses by being part of a system that enables reuse. 9 Virgin plastic means newly manufactured resin produced from petrochemical feedstock used as the raw material for the manufacture of plastic products and which has never been used or processed before.
